Back to News

Aragen receives Platinum Medal from EcoVadis for its sustainability initiativesFirst Indian Company to receive this highest global sustainability recognition

Hyderabad: Aragen Life Sciences, a globally renowned Contract Research, Development and Manufacturing Organization (CRDMO), has received the prestigious Platinum Medal rating from EcoVadis. This highest level of recognition places Aragen in the top 1% of companies worldwide for its exemplary sustainability practices. 

EcoVadis is widely respected as the global leader in business sustainability ratings, and its metrics evaluate over 150,000 companies across 175 countries. Its assessment is based on a thorough review of a company’s environmental, labor, ethical, and procurement practices. Significantly, Aragen Life Sciences is the only Indian headquartered company to receive the Platinum Medal in the EcoVadis 2024 assessment across all sectors. 

Commenting on the recognition, Manni Kantipudi, CEO, Aragen Life Sciences, said, “This is a testament to our commitment, dedication and passion towards building a sustainable and equitable future and a reflection of the progress we have made in this direction. We will continue to build an inclusive ecosystem that will not only help Aragen achieve its sustainability goals but also support our customers and partners in helping their goals as well.” 

During the last few years, Aragen has consistently improved its EcoVadis rating from 46 in 2021 to 82 in 2024. The company’s key sustainability initiatives include increasing its share of renewable energy, implementing green chemistry principles in R&D, and collaborating with suppliers to lower Scope 3 greenhouse gas emissions.  Aragen has prioritized water stewardship, employee-centric policies, and maintaining an ongoing dialogue with stakeholders in the sustainability sector. 

Aragen recently also received approval from Science Based Targets initiative (SBTi) for its near-term and net-zero sustainability targets. 

About Aragen:

Aragen Life Sciences is a globally renowned R&D and manufacturing solutions provider to the global life sciences and allied industries. It offers a range of solutions across the drug discovery, development and manufacturing continuum to advance small and large-molecule programs.  The Company operates through a global network of eight sites with a team of ~4500 employees and 450+ PhDs.  Its expertise and experience have enabled over 400 customers to advance their research programs from early discovery through development and commercialization. Aragen’s innovative mindset, infrastructure, flexible business models, clear purpose, and proprietary project management platform have enabled it to effectively scale and service large pharma, biotech, agrochemical, and animal health industries globally. Visit www.aragen.com for more details.